Nipocalimab Dose Selection for A Phase 3 Study in Adult Patients with Generalized Myasthenia Gravis

被引：2

作者：

Perez-Ruixo, Juan-Jose ^{[1
]}

Zhu, Yaowei ^{[1
]}

Neyens, Martine ^{[1
]}

Jouvin, Marie-Helene ^{[1
]}

Ramchandren, Sindhu ^{[1
]}

Xu, Yan ^{[1
]}

Leu, Jocelyn ^{[1
]}

Dosne, Anne-Gaelle ^{[1
]}

Xiong, Yuan ^{[1
]}

Valenzuela, Belen ^{[1
]}

Ling, Leona ^{[1
]}

Nandy, Partha ^{[1
]}

Sun, Hong ^{[1
]}

机构：

[1] Janssen Res & Dev, Raritan, NJ USA

来源：

NEUROLOGY | 2023年 / 100卷 / 17期

关键词：

D O I：

10.1212/WNL.0000000000203877

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P1-5.018

引用

页数：3

共 50 条

[21] Response to zilucoplan in the Phase 3 RAISE study in patients with generalised myasthenia gravis
Mantegazza, R.
Bresch, S.
Freimer, M.
Hewamadduma, C.
Leite, M.
Maniaol, A.
Schmidt, J.
Utsugisawa, K.
Vu, T.
Boroojerdi, B.
Lejdstrom, R. Beau
Duda, P.
Grimson, F.
Savic, N.
Howard, J., Jr.
EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 207 - 208
[22] ROZANOLIXIZUMAB IN GENERALIZED MYASTHENIA GRAVIS: RESPONDER ANALYSES FROM THE RANDOMIZED PHASE 3 MYCARING STUDY
Bril, Vera
Druzdz, Artur
Grosskreutz, Julian
Habib, Ali
Mantegazza, Renato
Sacconi, Sabrina
Utsugisawa, Kimiaki
Vissing, John
Vu, Tuan
Boehnlein, Marion
Bozorg, Ali
Gayfieva, Maryam
Woltering, Franz
Kaminski, Henry
MUSCLE & NERVE, 2022, 66 : S112 - S112
[23] ROZANOLIXIZUMAB IN PATIENTS AGED ≥65 YEARS WITH GENERALIZED MYASTHENIA GRAVIS: A POST HOC ANALYSIS OF THE PHASE 3 MYCARING STUDY
Vu, Tuan
Habib, Ali A.
Pascuzzi, Robert M.
Sacconi, Sabrina
Grimson, Fiona
Pulido-Valdeolivas, Irena
Tarancon, Thais
Bril, Vera
MUSCLE & NERVE, 2024, 70 (03) : 663 - 664
[24] TREATMENT OF PATIENTS WITH MYASTHENIA GRAVIS WITH EFGARTIGIMOD: RESULTS OF THE PHASE 3 ADAPT STUDY
Howard, J.
Vu, T.
Bril, V.
Peric, S.
Verschuuren, J.
Mantegazza, R.
Murai, H.
Ulrichts, P.
Guglietta, A.
de Haard, H.
Parys, W.
Beydoun, S.
Pasnoor, M.
Karam, C.
Muppidi, Sr
Bertorini, T.
Bhavaraju-Sanka, R.
Li, Y.
MUSCLE & NERVE, 2020, 62 : S125 - S126
[25] DISEASE BURDEN IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS
Silvestri, Nicholas
Ait-Tihyaty, Maria
Gandhi, Kavita
Turkoz, Ibrahim
Daskiran, Mehmet
Shaddinger, Bonnie C.
Lindenstrom, Ewa
MUSCLE & NERVE, 2024, 70 (03) : 652 - 653
[26] EFFECTS OF CORTICOTROPIN IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS
NAMBA, T
SHAPIRO, MS
ARIMORI, S
GROB, D
JOURNAL OF CLINICAL INVESTIGATION, 1967, 46 (06): : 1100 - &
[27] Comment: Methotrexate for patients with generalized myasthenia gravis
Drachman, Daniel B.
NEUROLOGY, 2016, 87 (01) : 63 - 63
[28] Frequency of seronegativity in adult-acquired generalized myasthenia gravis
Chan, Koon Ho
Lachance, Daniel H.
Harper, C. Michel
Lennon, Vanda A.
MUSCLE & NERVE, 2007, 36 (05) : 651 - 658
[29] Topline Results of a Phase 2 Study of Subcutaneous IMVT-1401 in Patients with Generalized Myasthenia Gravis
Benatar, Michael
Breiner, Ari
Bril, Vera
Nowak, Richard
Dunn, Imogene
Jacobs, Alan
NEUROLOGY, 2021, 96 (15)
[30] Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis
Howard, James F., Jr.
Bril, Vera
Burns, Ted M.
Mantegazza, Renato
Bilinska, Malgorzata
Szczudlik, Andrzej
Beydoun, Said
De Rivera Garrido, Francisco Javier Rodriguez
Piehl, Fredrik
Rottoli, Mariarosa
Van Damme, Philip
Tuan Vu
Evoli, Amelia
Freimer, Miriam
Mozaffar, Tahseen
Ward, E. Sally
Dreier, Torsten
Ulrichts, Peter
Verschueren, Katrien
Guglietta, Antonio
de Haard, Hans
Leupin, Nicolas
Verschuuren, Jan J. G. M.
Claeys, Kristl
Diez-Tejedor, Exuperio
Mathew, Veena
Sgarzi, Manlio
Harvey, Brittany Leigh
Farias, Jerrica
Frangiomore, Rita
Heintzman, Sarah
de Meel, Robert
Chopra, Manisha
Alboini, Paolo Emilio
Hietala, Albert
Genge, Angela
NEUROLOGY, 2019, 92 (23) : E2661 - E2673

← 1 2 3 4 5 →